星洲网
星洲网
星洲网 登入
Newsletter|星洲网 Newsletter 联络我们|星洲网 联络我们 登广告|星洲网 登广告 关于我们|星洲网 关于我们 活动|星洲网 活动

ADVERTISEMENT

ADVERTISEMENT

COVID-19

3月前
A patient from Selangor referred to UCSI Hospital at Bandar Springhill, Port Dickson was surprised and delighted to find retired Health director-general Tan Sri Dr Noor Hisham Abdullah as her attending doctor. To her and the rest of Malaysians, Dr Noor Hisham is regarded as a “Covid-19 hero”, a household name in Malaysia when he was the director-general of Health Ministry in 2020.  Wearing his white coat, he stood at the forefront of the pandemic battle in 2020, during a turbulent political period that saw Malaysia change prime ministers three times in three years. Some painted his portrait in tribute, children wrote heartfelt thank-you notes, and local artists immortalized his image in murals across the city to express their appreciation that he had led the medical team in Malaysia to combat Covid-19. On April 21, 2023, holding a bouquet of flowers, he retired from his long-held post as the Director-General of the Health Ministry after 35 years of public service, including 10 years as the director-general. Fading away from the limelight, Dr Noor Hisham does not lead a quiet life. Instead, he continues to save life at USCI hospital. “I’m very excited now! Although I retired from the government, my career in the private sector only began less than two years ago. This allows me to contribute more in private healthcare,” he said with a smile. In October 2023, less than half a year after leaving the public sector as the Director-General of Health Ministry, he was appointed chairman of UCSI Healthcare Group, based at Springhill Hospital in Port Dickson, Negeri Sembilan. Now, his week consists of two days of outpatient consultations, three days for surgeries, meetings or lectures, and the rest of the time is reserved for planning and strategizing. “Mondays and Wednesdays are my clinic days—I’m in the clinic until 3 or 4 p.m., reviewing reports and scans. On Tuesdays, Thursdays, and Fridays, I may be in the operating theatre or attending meetings with other hospitals,” he said. Driving private healthcare development With enthusiasm, he used his computer mouse to show the layout of UCSI hospital on screen. “Look, there are five entrances, so ambulances won’t get stuck…” He clicked to another image. “The hospital and surrounding facilities cover about 160 acres. Next door will be a Google data center, and across the road is a Chinese medical equipment manufacturer that will produce and export to the Asian market,” he said. He spoke at length about the hospital’s expansion plans and his vision for developing private healthcare—a new goal he’s pursuing post-retirement, pouring his time and energy back into his greatest passion. A surgeon at heart Noor Hisham, an endocrine surgeon specializing in breast cancer treatment, showed several clinical photographs—some bloody, some depicting rare and complex cases. While others might look away, he examined them intently, explaining with focus and certainty, emphasizing that Malaysia’s medical standards are on par with other countries. Seeing how much of his time is still spent on consultations, surgeries, and medical meetings, we […]
4月前
4月前
ANN
6月前
ANN
ANN
6月前
ANN
10月前
1年前
1年前
2年前
2年前
2年前
问:我在感染COVID-19病毒期间,一直干咳,我的朋友买了常春藤叶(Ivy leaf)止咳糖浆给我服用,想问这个药是传统草药还是一般的咳嗽药呢? 答:常春藤(Hedera nepalensis K,Koch var.sinensis(Tobl.)Rehd ,英文为Ivy)是一种五加科的藤蔓植物,叶子的部分可以用来制成药品,像是止咳糖浆,一种传统草药产品,主要用于缓解咳嗽症状。 由于常春藤叶萃取物被认为能刺激黏液腺,有助于肺部产生黏液将气管异物排出,亦能避免呼吸系统沉积过多的粘液,并具有祛痰和止咳的功效,因此可助于改善肺部功能,像治疗支气管炎、气喘和其他呼吸道疾病。 尽管常春藤叶止咳糖浆被广泛使用并且在一些研究中显示出一定的疗效,但尚未有确切研究足以完全佐证常春藤的功效原理,许多地区把它或其萃取物归类为传统疗法。 常春藤如同其他草药,并非人人都适合食用,且适合的使用量因人而异,取决于个人的年龄、健康状况等因素,请先和中医师或医师讨论后,以了解最适合自己的用量。 如果你刚被诊断感染COVID-19病毒并出现持续的干咳,建议咨询医生或中医师,并经过专业医护人员对症状和病情评估,再给予适当的治疗建议,包括是否适合使用常春藤叶止咳糖浆或其他咳嗽药物。 更多【问药】: 陈诗欣/市售10ml的眼药水和0.8ml的包装眼药水有什么差别?用错会导致眼睛问题吗?  陈诗欣/我有节食和吃减肥药,但都没有效。减肥药,都会有副作用吗?有没有即有效又不会伤身体的?  陈诗欣/未知怀孕仍服避孕药,会对宝宝造成什么影响吗? 药物应该怎么吃才有效?读者所有问题,可电邮到:[email protected]。  
2年前
2年前
2年前
问:我是肺癌第一期患者,5年前切除后每年复查都正常,直到我在两年前注射COVID-19疫苗后,病情复发转移到脑。我身边很多朋友在接种疫苗后,病情复发,请问癌症复发和接种COVID-19疫苗有关系吗? 答:目前尚未有足够的证据表明接种COVID-19疫苗会导致肺癌复发或转移至其他器官,因为这些疫苗并不直接与癌症有关。 然而,数据显示接种疫苗可能会对免疫系统产生一定的影响,从而可能会对肺癌复发和转移产生一定的影响。一些研究表明,接种疫苗后可能会增强免疫系统的反应,从而对肿瘤细胞进行攻击。但是,同一时间也有研究发现,疫苗接种可能会导致免疫系统的不适当反应,从而可能会增加癌症或复发的风险。这些影响可能会因个体差异而有所不同。 从流行病学的角度比较癌症的发病率和接种COVID-19疫苗后的癌症发病率之间的关系,需要考虑许多因素,例如年龄、性别、生活方式等。此外,癌症也是一种复杂的疾病,由多种因素交互作用而成。因此,难以简单地将接种COVID-19疫苗与癌症的病发率直接联系起来。 即便如此, 科学家依然可以使用大量的流行病学数据来评估癌症的病发率,并对它进行比较。例如,可以比较不同年龄组、性别和地理位置的癌症患病率,以及这些患病率在不同时间段的变化情况,其中,包括接种COVID-19疫苗的影响。但是,疫苗接种的时间还相对较短,而癌症病发和复发并不是一时半刻间发生的疾病,所以暂时尚无足够的数据来支持它对癌症病发和复发率影响的评估,研究人员需要进行更多的研究才能确定疫苗接种和癌症发病率之间是否存在关系。 【问药】其他文章: 林仁吉/化疗点滴输入后,我的静脉变得僵硬,皮肤非常紧绷,手指僵硬,请问中医能怎样治疗?  林仁吉/忧郁症会导致癌症吗?中医怎么看? 林仁吉/关于双腿静脉曲张,中西医有什么诊治方法? 林仁吉/中医治疗能否缓解或降低前列腺放疗时出现的肠胃道气体? 药物应该怎么吃才有效?读者所有问题,可电邮到:[email protected]
2年前
2年前